Contineum Therapeutics Statistics

Total Valuation

CTNM has a market cap or net worth of $99.09 million. The enterprise value is -$99.41 million.

Market Cap	99.09M
Enterprise Value	-99.41M

Important Dates

The next estimated earnings date is Friday, May 23, 2025, before market open.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

CTNM has 25.87 million shares outstanding. The number of shares has increased by 469.95% in one year.

Current Share Class	19.14M
Shares Outstanding	25.87M
Shares Change (YoY)	+469.95%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	2.02%
Owned by Institutions (%)	40.13%
Float	13.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.50
P/TBV Ratio	0.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 20.69, with a Debt / Equity ratio of 0.03.

Current Ratio	20.69
Quick Ratio	20.53
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -26.19% and return on invested capital (ROIC) is -19.30%.

Return on Equity (ROE)	-26.19%
Return on Assets (ROA)	-18.53%
Return on Invested Capital (ROIC)	-19.30%
Return on Capital Employed (ROCE)	-25.09%
Revenue Per Employee	n/a
Profits Per Employee	-$1.03M
Employee Count	41
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.77% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-75.77%
50-Day Moving Average	5.65
200-Day Moving Average	12.82
Relative Strength Index (RSI)	31.90
Average Volume (20 Days)	88,346

Short Selling Information

The latest short interest is 577,640, so 2.23% of the outstanding shares have been sold short.

Short Interest	577,640
Short Previous Month	688,871
Short % of Shares Out	2.23%
Short % of Float	4.39%
Short Ratio (days to cover)	7.09

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-50.89M
Pretax Income	n/a
Net Income	-42.26M
EBITDA	-50.64M
EBIT	-50.89M
Earnings Per Share (EPS)	-$2.18

Full Income Statement

Balance Sheet

The company has $204.76 million in cash and $6.26 million in debt, giving a net cash position of $198.50 million or $7.67 per share.

Cash & Cash Equivalents	204.76M
Total Debt	6.26M
Net Cash	198.50M
Net Cash Per Share	$7.67
Equity (Book Value)	198.07M
Book Value Per Share	7.66
Working Capital	196.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$32.85 million and capital expenditures -$514,000, giving a free cash flow of -$33.36 million.

Operating Cash Flow	-32.85M
Capital Expenditures	-514,000
Free Cash Flow	-33.36M
FCF Per Share	-$1.29

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CTNM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-469.95%
Shareholder Yield	-469.95%
Earnings Yield	-42.65%
FCF Yield	-33.67%

Analyst Forecast

The average price target for CTNM is $23.75, which is 520.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$23.75
Price Target Difference	520.10%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1